Zielinski CC - Search Results

1

[Effect of various factors on survival after recurrent and/or metastatic breast cancer].

Sevelda P, Kührer I, Zielinski CC, Vavra N, Seifert M, Kubista E, Czerwenka K, Spona J, Salzer H. Sevelda P, et al. Among authors: zielinski cc. Geburtshilfe Frauenheilkd. 1991 May;51(5):387-92. doi: 10.1055/s-2007-1026164. Geburtshilfe Frauenheilkd. 1991. PMID: 1869009 Clinical Trial. German.

2

Association of increased lytic effector cell function with high estrogen receptor levels in tumor-bearing patients with breast cancer.

Zielinski CC, Tichatschek E, Müller C, Kalinowski W, Sevelda P, Czerwenka K, Kubista E, Spona J. Zielinski CC, et al. Cancer. 1989 May 15;63(10):1985-9. doi: 10.1002/1097-0142(19890515)63:10<1985::aid-cncr2820631019>3.0.co;2-b. Cancer. 1989. PMID: 2702570

3

[Effect of hormone receptors on the site of metastases in breast cancer].

Stuller I, Zielinski CC, Aiginger P, Rausch P, Pötzi P, Kubista E, Salzer H, Sevelda P, Langer M, Staffen A, et al. Stuller I, et al. Among authors: zielinski cc. Onkologie. 1987 Oct;10(5):302-3. doi: 10.1159/000216427. Onkologie. 1987. PMID: 3317171 Free article. German. No abstract available.

4

[Significance of hormone receptors of breast cancer cells for the duration of a disease-free interval].

Zielinski CC, Kuzmits R, Kubista E, Salzer H, Staffen A, Aiginger P, Spona J. Zielinski CC, et al. Wien Klin Wochenschr. 1985 May 24;97(11):493-7. Wien Klin Wochenschr. 1985. PMID: 4013343 German.

5

Diagnostic value of mucin-like carcinoma-associated antigen (MCA) in breast cancer.

Rasoul-Rockenschaub S, Zielinski CC, Kubista E, Vavra N, Pospischil E, Staffen A, Czerwenka K, Aiginger P, Spona J. Rasoul-Rockenschaub S, et al. Among authors: zielinski cc. Eur J Cancer Clin Oncol. 1989 Jul;25(7):1067-72. doi: 10.1016/0277-5379(89)90390-8. Eur J Cancer Clin Oncol. 1989. PMID: 2759162

6

Tissue expression and serum levels of HER-2/neu in patients with breast cancer.

Krainer M, Brodowicz T, Zeillinger R, Wiltschke C, Scholten C, Seifert M, Kubista E, Zielinski CC. Krainer M, et al. Among authors: zielinski cc. Oncology. 1997 Nov-Dec;54(6):475-81. doi: 10.1159/000227606. Oncology. 1997. PMID: 9394844

7

Adjuvant tamoxifen in postmenopausal patients with breast cancer and negative axillary lymph nodes.

Scholten C, Sevelda P, Kurz C, Salzer H, Kubista E, Staffen A, Czerwenka K, Spona J, Aiginger P, Zielinski CC. Scholten C, et al. Among authors: zielinski cc. Eur J Cancer. 1992;28A(12):2083. doi: 10.1016/0959-8049(92)90261-y. Eur J Cancer. 1992. PMID: 1419306 Clinical Trial. No abstract available.

8

Adjuvant tamoxifen in postmenopausal stage II breast cancer five years on.

Mikl J, Aiginger P, Czerwenka K, Kubista E, Salzer H, Sevelda P, Spona J, Staffen A, Zielinski CC. Mikl J, et al. Among authors: zielinski cc. Lancet. 1990 Mar 3;335(8688):541. doi: 10.1016/0140-6736(90)90775-z. Lancet. 1990. PMID: 1968551 Clinical Trial. No abstract available.

9

Impaired production of tumor necrosis factor in breast cancer.

Zielinski CC, Mueller C, Tyl E, Tichatschek E, Kubista E, Spona J. Zielinski CC, et al. Cancer. 1990 Nov 1;66(9):1944-8. doi: 10.1002/1097-0142(19901101)66:9<1944::aid-cncr2820660916>3.0.co;2-w. Cancer. 1990. PMID: 2224791

10

Long-term influence of adjuvant therapy on natural killer cell activity in breast cancer.

Tichatschek E, Zielinski CC, Müller C, Sevelda P, Kubista E, Czerwenka K, Spona J, Wolf H, Eibl MM. Tichatschek E, et al. Among authors: zielinski cc. Cancer Immunol Immunother. 1988;27(3):278-82. doi: 10.1007/BF00205452. Cancer Immunol Immunother. 1988. PMID: 2460239 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

491 results

Search Page

Filters